Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)
Clinical trial NCT02735850 · WITHDRAWN
Trial details
- NCT number
- NCT02735850
- Sponsor
- Maastricht Radiation Oncology
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2021-02-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.